These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4305396)

  • 1. Immunogenicity of namogram to milligram quantities of inactivated foot-and-mouth disease virus. I. Relative virus-neutralizing potency of guinea pig sera.
    Morgan DO; Bachrach HL; McKercher PD
    Appl Microbiol; 1969 Mar; 17(3):441-5. PubMed ID: 4305396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of acetylethyleneimine upon a strain of inactivated foot-and-mouth disease virus stored at 4 degrees C.
    Staple RF; Morrow AW; Fletton BW
    Arch Virol; 1975; 47(4):331-5. PubMed ID: 166627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of foot-and-mouth disease virus with ethylenimine.
    Cunliffe HR
    Appl Microbiol; 1973 Nov; 26(5):747-50. PubMed ID: 4357652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines.
    Twomey T; Newman J; Burrage T; Piatti P; Lubroth J; Brown F
    Vaccine; 1995 Nov; 13(16):1603-10. PubMed ID: 8578849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The inactivation of foot-and-mouth disease virus by ethylethyleneimine and the use of the inactivated virus in the preparation of vaccines].
    Bauer K
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):285-97. PubMed ID: 4318509
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection of guinea-pigs against foot-and-mouth disease by simultaneous inoculation of sendai virus and inactivated foot-and-mouth disease vaccine.
    Herniman KA; Sellers RF
    Arch Gesamte Virusforsch; 1972; 37(1):97-103. PubMed ID: 4336969
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitation of the antigenicity and immunogenicity of purified foot-and-mouth disease virus vaccine for swine and steers.
    Morgan DO; McKercher PD; Bachrach HL
    Appl Microbiol; 1970 Nov; 20(5):770-4. PubMed ID: 4320865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
    Warrington RE; Cunliffe HR; Bachrach HL
    Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of some immunological methods for the differentiation of strains of foot-and-mouth disease virus.
    Forman AJ
    J Hyg (Lond); 1975 Apr; 74(2):215-25. PubMed ID: 164500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural differences between foot-and-mouth disease and poliomyelitis viruses influence their inactivation by aziridines.
    Burrage T; Kramer E; Brown F
    Vaccine; 2000 May; 18(22):2454-61. PubMed ID: 10738103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of nanogram to milligram quantities of inactivated foot-and-mouth disease virus. II. Comparative response of guinea pigs and steers.
    Morgan DO; McKercher PD; Bachrach HL
    Proc Annu Meet U S Anim Health Assoc; 1968; 72():407-15. PubMed ID: 4308554
    [No Abstract]   [Full Text] [Related]  

  • 12. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production.
    Bahnemann HG
    Arch Virol; 1975; 47(1):47-56. PubMed ID: 167679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Binary ethyleneimine as an inactivator of the foot-and-mouth disease virus].
    Tekerlekov P; Veleva E
    Vet Med Nauki; 1985; 22(3):3-8. PubMed ID: 2986348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of foot-and-mouth disease vaccines containing endonuclease-inactivated virions.
    Amadori M; Barei S; Melegari M; Panina GF
    Vaccine; 1987 Sep; 5(3):219-22. PubMed ID: 2823495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Production of purified foot-and-mouth disease virus antigens and the specific sera against them].
    Tekerlekov P; Nikolova E; Vasileva L
    Vet Med Nauki; 1978; 15(6):21-8. PubMed ID: 85363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1.
    Rao MG; Butchaiah G; Sen AK
    Vet Microbiol; 1994 Mar; 39(1-2):135-43. PubMed ID: 8203119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilizing the immunizing antigen of foot-and-mouth disease virus by fixation with formaldehyde.
    Rowlands DJ; Sangar DV; Brown F
    Arch Gesamte Virusforsch; 1972; 39(1):274-83. PubMed ID: 4344146
    [No Abstract]   [Full Text] [Related]  

  • 18. [The use of diethylaminoethyl-dextran (DEAE-D) as adjuvant for immunization of guinea pigs with inactivated foot-and-mouth disease (FMD) virus].
    Wittmann G
    Zentralbl Bakteriol Orig; 1970; 213(1):1-8. PubMed ID: 4318268
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of foot-and-mouth disease virus strains by complement fixation. I. A model for the fixation of complement by antigen-antibody mixtures.
    Forman AJ
    J Hyg (Lond); 1974 Jun; 72(3):397-405. PubMed ID: 4367223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of normal guinea-pig serum and tissue culture assay system on foot-and-mouth disease virus neutralisation.
    Ferris NP; Donaldson AI
    Comp Immunol Microbiol Infect Dis; 1983; 6(2):161-9. PubMed ID: 6189669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.